SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002319
Filing Date
2019-04-17
Accepted
2019-04-17 16:35:35
Documents
8
Period of Report
2019-05-29
Effectiveness Date
2019-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238442zdef14a.htm DEF 14A 643361
2 G68969.JPG g68969.jpg GRAPHIC 499
3 G610796.JPG g610796.jpg GRAPHIC 499
4 G957039.JPG g957039.jpg GRAPHIC 497
5 G450859.JPG g450859.jpg GRAPHIC 1228
6 G937289.JPG g937289.jpg GRAPHIC 497
7 G82132BGI001.JPG g82132bgi001.jpg GRAPHIC 111216
8 G82132BGI002.JPG g82132bgi002.jpg GRAPHIC 98290
  Complete submission text file 0001047469-19-002319.txt   938232
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38492 | Film No.: 19753391
SIC: 2834 Pharmaceutical Preparations